Gus Attridge gains over $18 million as Aspen shares rebound
This follows a strong recovery in Aspen's share price on the Johannesburg Stock Exchange (JSE).
Gus Attridge
South African tycoon Gus Attridge loses $15.73 Million as Aspen stake sinks
Attridge, co-founder and group chief advisor of Aspen Pharmacare, holds a 4.3-percent stake in the company.
Gus Attridge’s stake in Africa’s largest pharma company drops by $12 million
His 19,188,850 shares are now valued at R3.24 billion ($175.82 million), reflecting the latest decline in Aspen’s stock price.
South African businessman Gus Attridge sees Aspen stake drop by $9.3 million
This corresponds to a 5.24 percent drop in Aspen’s stock price on the Johannesburg Stock Exchange (JSE) in 9 days.
Gus Attridge's Aspen stake down $39 million so far in 2024
This corresponds to an 18.12 percent drop in Aspen’s stock price on the Johannesburg Stock Exchange (JSE) since the start of the year.
Gus Attridge’s stake in Africa’s largest pharma company drops by $16.5 million
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Aspen’s market slump wipes $52 million from South African tycoon Gus Attridge’s stake
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
South African tycoon Gus Attridge rakes in $6.2 million from Aspen shares
This follows a $12 million gain recorded between April 23 and May 3, when his stake rose from R4.07 billion ($219.65 million) to R4.29 billion ($231.65 million).
South African tycoon Gus Attridge gains nearly $12 million from Aspen shares
Attridge, Aspen’s group chief advisor, and a JSE heavyweight, holds a 4.3-percent stake in the pharmaceutical company, amounting to 19,033,829 ordinary shares.
South African tycoon Gus Attridge gains $7.95 million from Aspen shares
The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake in Aspen grew by R447.12 million ($25.12 million).
South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
South African tycoon Gus Attridge suffers $8-million loss from Aspen shares
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African tycoon Gus Attridge gains nearly $8 million in 16 days
Attridge, Aspen’s group chief advisor who ranks as one of JSE’s richest investors, owns a 4.26-percent stake in the pharma group.
South African tycoon Gus Attridge rakes in $19 million from Aspen shares
The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 and Oct. 26.